Clinical Trials Logo
  1. Home
  2. Allergy
  3. NCT03182491
  4. Details
NCT03182491 Clinical Trial

Mechanisms of Anaphylaxis

Allergy Clinical Trial

— ANAMEK  

Official title:
Mechanisms of Anaphylaxis

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT03182491
Other study ID # 2016/1635
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date April 28, 2017
Est. completion date October 1, 2026

Study information
Verified date August 2022
Source Haukeland University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to explore different mechanisms for anaphylaxis and find novel biomarkers for this hypersensitivity syndrome. The study participants are patients with anaphylaxis, patients with mild allergic reactions, and patients with febrile transfusion reactions. The investigators will also include a group of healthy controls.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 40
Est. completion date October 1, 2026
Est. primary completion date October 1, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years to 120 Years
Eligibility Inclusion Criteria: According to the specific cohort: 1. Diagnosis of anaphylaxis 2. Mild allergic reaction 3. Febrile transfusion reaction 4. Healthy, no known allergic disease Exclusion Criteria: Suspicion or diagnosed sepsis Children

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Biomarkers (platelet activating factor [PAF], anaphylatoxins) and basophil activation test (BAT)
Analysis of biomarkers and basophil activation test

Locations
Country Name City State
Norway Haukeland University Hospital Bergen

Sponsors (1)
Lead Sponsor Collaborator
Haukeland University Hospital

Country where clinical trial is conducted

Norway, 

Outcome
Type Measure Description Time frame Safety issue
Primary Clarify mechanisms for anaphylaxis and establish biomarkers for this syndrome Immunological/nonimmunological mechanism 2 days
See also
  Status Clinical Trial Phase
Terminated NCT02032056 - Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period N/A
Completed NCT01842711 - Cumulative Irritation Patch Test N/A
Completed NCT01633840 - New Validated Recipes for Double-blind Placebo-controlled Low Dose Food Challenges N/A
Completed NCT00554983 - Efficacy and Safety From a Recombinant Folding Variant of Bet v 1 Phase 3
Completed NCT00997971 - Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein Phase 3
Completed NCT00331929 - Respiratory Health Study of Children in Kiryat Tivon N/A
Completed NCT00232518 - Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis N/A
Completed NCT00220753 - Air Cleaners for Children and Adolescents With Asthma and Dog Allergy N/A
Completed NCT04126096 - Negative Predictive Value and NIC of Beta-Lactam Antibiotics. N/A
Completed NCT04046731 - Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation N/A
Completed NCT04004351 - Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma
Not yet recruiting NCT05997784 - Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing
Completed NCT04418999 - Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus Early Phase 1
Completed NCT04186949 - Early Origins of Allergy and Asthma
Completed NCT02127801 - Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants Phase 1
Enrolling by invitation NCT05011071 - The Alberta BLOOM Premature Child Study
Not yet recruiting NCT06330974 - Allergy, Asthma, and Atopic Eczema in Finland
Terminated NCT02601690 - Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America
Completed NCT02596321 - A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma Phase 3
Completed NCT02306473 - The Leaky Lung Test Early Phase 1